PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2458948-0	1988	Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.	Eflornithine	163-167	myeloblastosis oncogene	Mus musculus	62-67	
2458948-0	1988	Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.	Eflornithine	163-167	transformation related protein 53, pseudogene	Mus musculus	73-76	
2458948-0	1988	Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.	Dimethyl Sulfoxide	172-176	myeloblastosis oncogene	Mus musculus	62-67	
2458948-0	1988	Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.	Dimethyl Sulfoxide	172-176	transformation related protein 53, pseudogene	Mus musculus	73-76	
2458948-4	1988	In contrast, treatment of the cells with DFMO resulted in gradual cessation of cell replication and a decrease in transcription of c-myc, c-myb and p53.	Eflornithine	41-45	myeloblastosis oncogene	Mus musculus	138-143	
2458948-4	1988	In contrast, treatment of the cells with DFMO resulted in gradual cessation of cell replication and a decrease in transcription of c-myc, c-myb and p53.	Eflornithine	41-45	transformation related protein 53, pseudogene	Mus musculus	148-151	
2458948-5	1988	When the MEL cells were induced to differentiate with dimethyl sulfoxide (DMSO), a transient reduction in c-myc and c-myb RNA levels occurred immediately prior to the G1 arrest with a concomitant decrease in transcriptional activity, while p53 mRNA production was elevated without an increase in transcription.	Dimethyl Sulfoxide	54-72	myeloblastosis oncogene	Mus musculus	116-121	
2458948-5	1988	When the MEL cells were induced to differentiate with dimethyl sulfoxide (DMSO), a transient reduction in c-myc and c-myb RNA levels occurred immediately prior to the G1 arrest with a concomitant decrease in transcriptional activity, while p53 mRNA production was elevated without an increase in transcription.	Dimethyl Sulfoxide	54-72	transformation related protein 53, pseudogene	Mus musculus	240-243	
2458948-5	1988	When the MEL cells were induced to differentiate with dimethyl sulfoxide (DMSO), a transient reduction in c-myc and c-myb RNA levels occurred immediately prior to the G1 arrest with a concomitant decrease in transcriptional activity, while p53 mRNA production was elevated without an increase in transcription.	Dimethyl Sulfoxide	74-78	myeloblastosis oncogene	Mus musculus	116-121	
2458948-5	1988	When the MEL cells were induced to differentiate with dimethyl sulfoxide (DMSO), a transient reduction in c-myc and c-myb RNA levels occurred immediately prior to the G1 arrest with a concomitant decrease in transcriptional activity, while p53 mRNA production was elevated without an increase in transcription.	Dimethyl Sulfoxide	74-78	transformation related protein 53, pseudogene	Mus musculus	240-243	
2458948-7	1988	From these experiments we conclude that (i) c-myc, c-myb, and p53 are regulated independently at both the transcriptional and post-transcriptional levels, (ii) DFMO inhibits MEL cell proliferation and expression of several genes, including c-myc, c-myb and p53, and (iii) DFMO suppresses terminal differentiation but is unable to alter proto-oncogene changes associated with the early stages of differentiation.	Eflornithine	160-164	myeloblastosis oncogene	Mus musculus	51-56	
2458948-7	1988	From these experiments we conclude that (i) c-myc, c-myb, and p53 are regulated independently at both the transcriptional and post-transcriptional levels, (ii) DFMO inhibits MEL cell proliferation and expression of several genes, including c-myc, c-myb and p53, and (iii) DFMO suppresses terminal differentiation but is unable to alter proto-oncogene changes associated with the early stages of differentiation.	Eflornithine	160-164	transformation related protein 53, pseudogene	Mus musculus	62-65	
2458948-7	1988	From these experiments we conclude that (i) c-myc, c-myb, and p53 are regulated independently at both the transcriptional and post-transcriptional levels, (ii) DFMO inhibits MEL cell proliferation and expression of several genes, including c-myc, c-myb and p53, and (iii) DFMO suppresses terminal differentiation but is unable to alter proto-oncogene changes associated with the early stages of differentiation.	Eflornithine	160-164	myeloblastosis oncogene	Mus musculus	247-252	
2458948-7	1988	From these experiments we conclude that (i) c-myc, c-myb, and p53 are regulated independently at both the transcriptional and post-transcriptional levels, (ii) DFMO inhibits MEL cell proliferation and expression of several genes, including c-myc, c-myb and p53, and (iii) DFMO suppresses terminal differentiation but is unable to alter proto-oncogene changes associated with the early stages of differentiation.	Eflornithine	160-164	transformation related protein 53, pseudogene	Mus musculus	257-260